Overall rank by patents
#24,537
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 17 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).
The verdict
According to USPTO PatentsView, Indorma ranks #24,537 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 17 technology areas.
USPTO PatentsView assignee plate
Corpus R24537 · US Corporation #24,537 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Imagescan, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Indorma Ventures Oxi… · this assignee
37 score
3D Lighting Innovati… · lowest
7 score
What this shows Indorma's Innovation Score is 37.2/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Indorma Ventures Oxides Llc is a focused PatentsView assignee: 17 CPC subclasses with 45.5% of grants classified under A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2023. By volume, Indorma sits between Imagescan, Inc. and Inhibrx Biosciences, Inc..
Indorma Ventures Oxides Llc shows 5 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ImageScan, Inc.
11 patents
Imago Biosciences, Inc.
11 patents
InCarda Therapeutics, Inc.
11 patents
Indian Ocean Medical Inc.
11 patents
Industrilås i Nässjö Aktiebolag
11 patents
Infinitum Solutions, Inc.
11 patents
Information Resources, Inc.
11 patents
Inhibrx Biosciences, Inc.
11 patents
Indorma Ventures Oxides LLC
11 patents
What this shows Indorma holds 11 patents at rank #24,552, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,552 in granted patent volume.
Other assignees with the most granted patents in Indorma's primary technology class.
Indorma's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 44% higher than 56% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 18.2% |
| 2021 | 4 | 36.4% |
| 2022 | 3 | 27.3% |
| 2023 | 1 | 9.1% |
| 2024 | 1 | 9.1% |
Top 15 of 17 technology areas
Overall rank by patents
#24,537
of 50,000 tracked assignees
37.2 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.